0001677300-16-000002.txt : 20160621
0001677300-16-000002.hdr.sgml : 20160621
20160621192231
ACCESSION NUMBER: 0001677300-16-000002
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160614
FILED AS OF DATE: 20160621
DATE AS OF CHANGE: 20160621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KARABELAS ARGERIS N
CENTRAL INDEX KEY: 0001191229
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 161725402
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2016-06-14
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001191229
KARABELAS ARGERIS N
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
0
0
0
No Securities beneficially owned.
0
D
No Derivative Securities beneficially owned.
No Derivative Securities beneficially owned.
0
D
No Securities beneficially owned.
Robert Chai-Onn for Argeris N. Karabelas
2016-06-21